Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2

Sponsor
University of Turin, Italy (Other)
Overall Status
Completed
CT.gov ID
NCT05896319
Collaborator
(none)
36
1
2
6
6

Study Details

Study Description

Brief Summary

The aim of the present split-mouth study was to investigate the effect of Hyaluronic Acid (HA) in improving the post-extraction tooth socket healing in subjects with diabetes mellitus type 2.

The null hypothesis was that HA can significantly improve the post extractive healing of diabetic patients compared with no treatment.

36 patients with diabetes mellitus type 2 requiring bilateral extraction of the homologous, not included, teeth were enrolled. After the extractions carried out in the same appointment, following the split-mouth design of the study, one site was randomly assigned to the test (T) group, while the other one was assigned to the control group (C).

T group included: Post-operative application of Hyaluronic acid gels 3 times per day

C group included: no treatment.

Patients were then followed after 3, 7,14 and 21 days and the healing of each socket was evaluated and compared between the 2 groups.

Condition or Disease Intervention/Treatment Phase
  • Device: Hyaluronic acid gel
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
split-mouthsplit-mouth
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Hyaluronic and Synthetic Amino Acids Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2: a Split-mouth Study
Actual Study Start Date :
Sep 7, 2022
Actual Primary Completion Date :
Feb 8, 2023
Actual Study Completion Date :
Mar 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment group

Postoperative application of hyaluronic acid gels 3 times per day for 7 days after tooth extraction

Device: Hyaluronic acid gel
Post-operative application of Hyaluronic acid gel 3 times per day (8 hours distance between each application) for 7 days after oral hygiene and without swallowing, eating or drinking for one hour after the application, as follows: "wash your hands thoroughly before each application, apply a layer of gel on the injured mucosa, massage with a finger in order to facilitate spreading of the product over the treated area".

No Intervention: Control group

No adjunctive therapy undergoing natural healing

Outcome Measures

Primary Outcome Measures

  1. Change in healing index [After 3, 7, 14, and 21 days from the extraction]

    3 possible scores for each of the 4 parameters considered: tissue color (1= 100% pink gum; 2=<50% hyperemic gum ; 3=>50% hyperemic gingiva), bleeding (1=absent; 2=provoked by palpation; 3=spontaneous), granulation tissue (1=pink and firm; 2=red and soft; 3=brittle), suppuration ( 1=no accumulation of plaque on the margins; 2=evident plaque on the margins; 3=suppuration/alveolitis). In this index, a score of 4 corresponds to excellent healing, conversely a score of 12 corresponds to very poor healing.

  2. Change in residual socket volume [After 3, 7, 14, and 21 days from the extraction]

    Ratio between the volume of the healing socket at a given Time and the volume of the socket at T0. It was calculated by measuring (millimeters) the maximum oral-vestibule (OV) diameter, the maximum mesio-distal (MD) diameter, and the maximum socket depth (SD). MD diameter was measured in the point of the maximum MD width of the socket both for single-rooted and multi-rooted teeth. OV diameter was measured in the point of the maximum vestibule-oral width of the socket or of each root (considering only the maximum value for the pluri-rooted teeth). SD was measured as the distance between the gingival margin and the socket bone in the point of its maximum depth (without forcing the probe).

Secondary Outcome Measures

  1. Change in pain assessment [After 3, 7, 14, and 21 days from the extraction]

    Visual Analogue Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age ≥ 18 years old

  • diabetic type 2 patients with glycaemia levels under control but with a positive history for diabetes complications (e.g., nephropathy, neuropathy, retinopathy, cardiopathy, peripheral vascular disease)

  • agreement to be enrolled in the study

  • availability to come at the control visit

Exclusion Criteria:
  • presence of platelet dysfunction

  • presence of thrombocytopenia

  • corticosteroid treatment

  • smokers

  • refusal to participate in the study

  • assumption of drugs possibly interacting with the wound healing

  • extractions requiring the elevation of a flap

Contacts and Locations

Locations

Site City State Country Postal Code
1 C.I.R Dental School, University of Turin Turin Italy 10126

Sponsors and Collaborators

  • University of Turin, Italy

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Massimo Carossa, Doctor, University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT05896319
Other Study ID Numbers:
  • Unito-DM2022
First Posted:
Jun 9, 2023
Last Update Posted:
Jun 9, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2023